The packaging capacity of adeno‐associated virus (AAV) and the potential for wild‐type‐plus AAV gene therapy vectors
Authors:
Open Access
- 21 April 1997
- journal article
- Published by Wiley in FEBS Letters
- Vol. 407 (1) , 78-84
Abstract
Because of its ability to integrate chromosomally and its non‐pathogenic nature, adeno‐associated virus (AAV) has significant potential as a human gene therapy vector. Here we investigate the maximum amount of DNA which can be inserted into the AAV genome and still allow efficient packaging into an infectious virus particle. Altered wild‐type AAV genomes were constructed with inserts, which increased in size by 100 bp, ligated at map unit 96. These large wild‐type‐plus genomes were able to replicate and produce infectious virus, at levels slightly reduced but comparable to normal sized wild type, until the insert size reached 1 kb. These data indicate that the maximum effective packaging capacity of AAV is approximately 900 bp larger than wild type, or 119%. Furthermore, it is demonstrated that these large AAV genomes are able to latently infect cells by chromosomal integration as does wild‐type AAV. These data suggest that therapy vectors carrying a foreign gene of 900 bp or less can be generated from AAV, by ligation into non‐essential locations, and result in a recombinant AAV virus with a fully wild‐type phenotype. Such wild‐type‐plus AAV vectors will have both advantages and disadvantages over defective recombinant AAV virus — the most important advantages being the ease in which high titers of infectious virus can be generated and the ability to specifically integrate within chromosome 19. Once the concern subsides over the presence of wild‐type AAV in clinical applications, wild‐type AAV vectors may find specific application niches for use in human gene therapy.Keywords
This publication has 25 references indexed in Scilit:
- High-Efficiency Transfer of the T Cell Co-Stimulatory Molecule B7-2 to Lymphoid Cells Using High-Titer Recombinant Adeno-Associated Virus VectorsHuman Gene Therapy, 1995
- DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.Proceedings of the National Academy of Sciences, 1995
- The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoterCancer Letters, 1994
- Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence.Proceedings of the National Academy of Sciences, 1994
- Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.Proceedings of the National Academy of Sciences, 1994
- Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types.Molecular and Cellular Biology, 1988
- Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.Proceedings of the National Academy of Sciences, 1984
- Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.Proceedings of the National Academy of Sciences, 1982
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975
- Selective extraction of polyoma DNA from infected mouse cell culturesJournal of Molecular Biology, 1967